The anti-CD6 mAb authorized for treating psoriasis in India (27) binds to
Chemexpress The anti-CD6 mAb approved for treating psoriasis in India (27) binds to, suggesting that this new CD6 ligand may have important roles in autoimmune conditions, distinct in the previously identified…